Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Disruptive Science and Technology: A New Journal

1/13/2012

Alan Russell, Ph.D., Editor in Chief

Early in 2012 Mary Ann Liebert, Inc. publishers will launch Disruptive Science and Technology, a bimonthly peer-reviewed journal that will publish game-changing research that has the potential to significantly improve human health, well-being, and productivity. The journal will present new and innovative results, essential data, cutting-edge discoveries, thorough syntheses and analyses, and publish out-of-the-box concepts.


During this week’s podcast, Dr. Alan Russell, founding director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh and editor in chief of Disruptive Science and Technology, talks about the need for such a journal. He discusses the key journal topics and describes how the journal’s articles will exemplify "game-changing" research.

Alan Russell (Ph.D. in Biological Chemistry, 1987, Imperial College of Science and Technology, University of London) is a Distinguished University Professor of Surgery and the Founding Director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh. Further, he holds positions as Professor in the departments of Bioengineering, Chemical Engineering and Rehabilitation Science and Technology. In addition to his appointments at the University, Dr. Russell is the Executive Director of the Pittsburgh Tissue Engineering Initiative, Inc., as well as a consultant for UPMC's International and Commercial Services Division. He has founded three biotechnology companies; ICX Agentase LLC, NanoSembly LLC, and O2Cyte LLC, and was also the Founding President of the 3,000-member Tissue Engineering and Regenerative Medicine International Society.

For the last 15 years, the Russell laboratory has been discovering what can be achieved by exploiting the rich interface of chemistry, biology, and materials. Dr. Russell's work has impacted fields as diverse as chemical and polymer synthesis to tissue engineering and homeland defense. Dr. Russell has pioneered how to make polymers from enzymes and how to incorporate enzymes into bulk polymers. In a series of discoveries, Dr. Russell's laboratory has found how to meld the synthetic and biological worlds.


Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll